Sales of Rx/reimbursement adult incontinence are expected to continue declining over the forecast period, though at a slower pace than in the review period. This is partly because the National Sanitary System and its regional branches have gradually streamlined their operations by reducing the inefficiencies that previously led to wastage of products and funding.
With an ageing population and a rising need for adult incontinence products, manufacturers can be expected to achieve better economies of scale and invest in innovation driven by higher margins from retail sales. As a result, public healthcare is projected to benefit from more advanced product features without directly funding research and development.
Pharmacies and parapharmacies will remain the main store-based outlets for accessing Rx/reimbursement adult incontinence products during the forecast period, prompting online pharmacies to refine their communication strategies for these products. People confronting incontinence for the first time require guidance on bureaucratic procedures as well as information on related health issues, making pharmacists a central point of reference.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Italy with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Italy, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsThis report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!